Venture Visionary Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Buy
14,155
+1,489
+12% +$1.52M 0.47% 53
2026
Q1
$11.6M Sell
12,666
-257
-2% -$261K 0.39% 68
2025
Q4
$14M Buy
12,923
+462
+4% +$442K 0.46% 50
2025
Q3
$9.51M Buy
12,461
+415
+3% +$309K 0.33% 81
2025
Q2
$9.39M Buy
12,046
+1,712
+17% +$1.33M 0.35% 70
2025
Q1
$8.54M Buy
10,334
+4,053
+65% +$3.37M 0.36% 73
2024
Q4
$4.85M Sell
6,281
-225
-3% -$186K 0.21% 117
2024
Q3
$5.76M Sell
6,506
-25
-0.4% -$22.5K 0.25% 104
2024
Q2
$5.91M Buy
6,531
+154
+2% +$123K 0.27% 101
2024
Q1
$4.96M Buy
6,377
+103
+2% +$73.3K 0.24% 107
2023
Q4
$3.66M Sell
6,274
-389
-6% -$227K 0.19% 125
2023
Q3
$3.58M Buy
6,663
+235
+4% +$121K 0.22% 113
2023
Q2
$3.01M Buy
6,428
+289
+5% +$121K 0.18% 130
2023
Q1
$2.11M Sell
6,139
-127
-2% -$42.8K 0.13% 144
2022
Q4
$2.29M Sell
6,266
-393
-6% -$139K 0.17% 124
2022
Q3
$2.15M Sell
6,659
-334
-5% -$106K 0.17% 116
2022
Q2
$2.27M Buy
6,993
+87
+1% +$26.1K 0.17% 111
2022
Q1
$1.98M Sell
6,906
-49
-0.7% -$12.6K 0.13% 142
2021
Q4
$1.91M Buy
6,955
+54
+0.8% +$13.7K 0.12% 145
2021
Q3
$1.59M Sell
6,901
-60
-0.9% -$14.8K 0.11% 156
2021
Q2
$1.6M Sell
6,961
-688
-9% -$138K 0.13% 150
2021
Q1
$1.43M Buy
7,649
+2,168
+40% +$424K 0.12% 153
2020
Q4
$925K Buy
+5,481
New +$818K 0.1% 164

Other funds holding LLY

Venture Visionary Partners's LLY Position: Q2 2026 in Review

Venture Visionary Partners increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $1.52M and bringing the position to 14,155 shares worth $17M. The position accounts for 0.47% of the portfolio, ranked #53.

Venture Visionary Partners first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Venture Visionary Partners held 14,155 shares of Eli Lilly worth $17M as of Q2 2026.
  • Venture Visionary Partners bought 1,489 Eli Lilly shares in Q2 2026, an estimated $1.52M.
  • Eli Lilly made up 0.47% of Venture Visionary Partners's portfolio in Q2 2026, its #53 holding.
  • Venture Visionary Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.